[HTML][HTML] Beyond weight loss: added benefits could guide the choice of anti-obesity medications
V Guglielmi, S Bettini, P Sbraccia, L Busetto… - Current obesity …, 2023 - Springer
Abstract Purpose of Review To highlight the added benefits of approved and upcoming,
centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and …
centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and …
Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications.
V Guglielmi, S Bettini, P Sbraccia, L Busetto… - Current Obesity …, 2023 - europepmc.org
To highlight the added benefits of approved and upcoming, centrally-acting, anti-obesity
drugs, focusing not only on the most common metabolic and cardiovascular effects but also …
drugs, focusing not only on the most common metabolic and cardiovascular effects but also …
Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications
V Guglielmi, S Bettini, P Sbraccia, L Busetto… - CURRENT OBESITY …, 2023 - art.torvergata.it
Purpose of ReviewTo highlight the added benefits of approved and upcoming, centrally-
acting, anti-obesity drugs, focusing not only on the most common metabolic and …
acting, anti-obesity drugs, focusing not only on the most common metabolic and …
[PDF][PDF] Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti‑Obesity Medications
V Guglielmi, S Bettini, P Sbraccia, L Busetto… - 2023 - sio-obesita.org
Abstract Purpose of Review To highlight the added benefits of approved and upcoming,
centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and …
centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and …
Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications
V Guglielmi, S Bettini, P Sbraccia… - CURRENT …, 2023 - avesis.istanbul.edu.tr
Purpose of ReviewTo highlight the added benefits of approved and upcoming, centrally-
acting, anti-obesity drugs, focusing not only on the most common metabolic and …
acting, anti-obesity drugs, focusing not only on the most common metabolic and …
Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications
V Guglielmi, S Bettini, P Sbraccia… - CURRENT OBESITY …, 2023 - research.unipd.it
Purpose of ReviewTo highlight the added benefits of approved and upcoming, centrally-
acting, anti-obesity drugs, focusing not only on the most common metabolic and …
acting, anti-obesity drugs, focusing not only on the most common metabolic and …
[HTML][HTML] Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications
V Guglielmi, S Bettini, P Sbraccia, L Busetto… - Current Obesity …, 2023 - ncbi.nlm.nih.gov
Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications
V Guglielmi, S Bettini, P Sbraccia, L Busetto… - CURRENT OBESITY …, 2023 - iris.unimore.it
Purpose of ReviewTo highlight the added benefits of approved and upcoming, centrally-
acting, anti-obesity drugs, focusing not only on the most common metabolic and …
acting, anti-obesity drugs, focusing not only on the most common metabolic and …
Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications
V Guglielmi, S Bettini, P Sbraccia… - Current obesity …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose of review To highlight the added benefits of approved and upcoming, centrally-
acting, anti-obesity drugs, focusing not only on the most common metabolic and …
acting, anti-obesity drugs, focusing not only on the most common metabolic and …
[PDF][PDF] Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti‑Obesity Medications
V Guglielmi, S Bettini, P Sbraccia, L Busetto… - 2023 - art.torvergata.it
Abstract Purpose of Review To highlight the added benefits of approved and upcoming,
centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and …
centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and …